Advertisement
Research Article Free access | 10.1172/JCI110269
Hemostasis Unit, Brigham and Women's Hospital, Boston, Massachusetts 02115
Hemostasis and Thrombosis Unit, Sidney Farber Cancer Institute, Boston, Massachusetts 02115
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Find articles by Rybak, M. in: JCI | PubMed | Google Scholar
Hemostasis Unit, Brigham and Women's Hospital, Boston, Massachusetts 02115
Hemostasis and Thrombosis Unit, Sidney Farber Cancer Institute, Boston, Massachusetts 02115
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Find articles by Lau, H. in: JCI | PubMed | Google Scholar
Hemostasis Unit, Brigham and Women's Hospital, Boston, Massachusetts 02115
Hemostasis and Thrombosis Unit, Sidney Farber Cancer Institute, Boston, Massachusetts 02115
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Find articles by Tomkins, B. in: JCI | PubMed | Google Scholar
Hemostasis Unit, Brigham and Women's Hospital, Boston, Massachusetts 02115
Hemostasis and Thrombosis Unit, Sidney Farber Cancer Institute, Boston, Massachusetts 02115
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Find articles by Rosenberg, R. in: JCI | PubMed | Google Scholar
Hemostasis Unit, Brigham and Women's Hospital, Boston, Massachusetts 02115
Hemostasis and Thrombosis Unit, Sidney Farber Cancer Institute, Boston, Massachusetts 02115
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115
Find articles by Handin, R. in: JCI | PubMed | Google Scholar
Published August 1, 1981 - More info
To determine the relationship between platelet secretion and prothrombin conversion in whole blood, the release of platelet factor 4 and the generation of a Xa-specific cleavage product of prothrombin, fragment 1 + 2, were measured during the coagulation of whole blood. There was a parallel increase in the concentration of the two proteins. Over the first 5 min of incubation, platelet factor 4 concentration increased 6 ng/ml per min, and after 6-7 min, the rate of release increased to 750 ng/ml per min. Over the initial 5-7 min of incubation, fragment 1 + 2 concentration increased 1.5 pmol/ml per min with a subsequent increase of 45 pmol/ml per min. Incubation with 10 μM prostaglandin E1 or 15 μM prostaglandin I2 inhibited secretion of platelet factor 4 and delayed the onset of the rapid phase of fragment 1 + 2 generation by 8 min, while stimulation of platelet secretion with 1 μg/ml collagen suspension enhanced production of fragment 1 + 2. The addition of either 10 μM epinephrine or 100 ng/ml collagen suspension to whole blood did not affect either platelet factor 4 release or fragment 1 + 2 generation, although the combination of 3 μM epinephrine and 100 ng/ml collagen suspension enhanced platelet release and prothrombin cleavage.
The relationship between platelet factor 4 release and prothrombin cleavage was also studied in Factor VIII-deficient blood. When 0.001 U/ml factor VIII activity was present, <80 ng/ml platelet factor 4 were released, and no fragment 1 + 2 was generated after 30 min of incubation. The addition of 0.008-0.08 U/ml Factor VIII activity progressively increased platelet factor 4 release and prothrombin cleavage. Platelet factor 4 release was normal at 0.08 U/ml Factor VIII activity, whereas prothrombin cleavage was still delayed. Very little thrombin, the amount generated by the cleavage of 3-5 nM fragment 1 + 2, was needed to induce release of platelet factor 4.